Literature DB >> 25230751

Different antigen-processing activities in dendritic cells, macrophages, and monocytes lead to uneven production of HIV epitopes and affect CTL recognition.

Jens Dinter1, Pauline Gourdain1, Nicole Y Lai1, Ellen Duong1, Edith Bracho-Sanchez1, Marijana Rucevic1, Paul H Liebesny1, Yang Xu1, Mariko Shimada1, Musie Ghebremichael1, Daniel G Kavanagh1, Sylvie Le Gall1.   

Abstract

Dendritic cells (DCs), macrophages (MPs), and monocytes are permissive to HIV. Whether they similarly process and present HIV epitopes to HIV-specific CD8 T cells is unknown despite the critical role of peptide processing and presentation for recognition and clearance of infected cells. Cytosolic peptidases degrade endogenous proteins originating from self or pathogens, exogenous Ags preprocessed in endolysosomes, thus shaping the peptidome available for endoplasmic reticulum translocation, trimming, and MHC-I presentation. In this study, we compared the capacity of DCs, MPs, and monocyte cytosolic extracts to produce epitope precursors and epitopes. We showed differences in the proteolytic activities and expression levels of cytosolic proteases between monocyte-derived DCs and MPs and upon maturation with LPS, R848, and CL097, with mature MPs having the highest activities. Using cytosol as a source of proteases to degrade epitope-containing HIV peptides, we showed by mass spectrometry that the degradation patterns of long peptides and the kinetics and amount of antigenic peptides produced differed among DCs, MPs, and monocytes. Additionally, variable intracellular stability of HIV peptides prior to loading onto MHC may accentuate the differences in epitope availability for presentation by MHC-I between these subsets. Differences in peptide degradation led to 2- to 25-fold differences in the CTL responses elicited by the degradation peptides generated in DCs, MPs, and monocytes. Differences in Ag-processing activities between these subsets might lead to variations in the timing and efficiency of recognition of HIV-infected cells by CTLs and contribute to the unequal capacity of HIV-specific CTLs to control viral load.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25230751      PMCID: PMC4201977          DOI: 10.4049/jimmunol.1400491

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  80 in total

1.  Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation.

Authors:  A Macagno; M Gilliet; F Sallusto; A Lanzavecchia; F O Nestle; M Groettrup
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

2.  Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.

Authors:  D López; B C Gil-Torregrosa; C Bergmann; M Del Val
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

3.  Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells.

Authors:  S Morel; F Lévy; O Burlet-Schiltz; F Brasseur; M Probst-Kepper; A L Peitrequin; B Monsarrat; R Van Velthoven; J C Cerottini; T Boon; J E Gairin; B J Van den Eynde
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

4.  MHC-I-restricted presentation of HIV-1 virion antigens without viral replication.

Authors:  F Buseyne; S Le Gall; C Boccaccio; J P Abastado; J D Lifson; L O Arthur; Y Rivière; J M Heard; O Schwartz
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

5.  ER aminopeptidases generate a unique pool of peptides for MHC class I molecules.

Authors:  T Serwold; S Gaw; N Shastri
Journal:  Nat Immunol       Date:  2001-07       Impact factor: 25.606

6.  MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells.

Authors:  A J Sijts; S Standera; R E Toes; T Ruppert; N J Beekman; P A van Veelen; F A Ossendorp; C J Melief; P M Kloetzel
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

7.  Human monocytes possess a serine protease activity capable of degrading HIV-1 reverse transcriptase in vitro.

Authors:  M T Château; V Robert-Hebmann; C Devaux; J B Lazaro; B Canard; O Coux
Journal:  Biochem Biophys Res Commun       Date:  2001-07-27       Impact factor: 3.575

8.  Inhibition of human immunodeficiency virus type 1 replication in primary CD4(+) T lymphocytes, monocytes, and dendritic cells by cytotoxic T lymphocytes.

Authors:  M E Severino; N V Sipsas; P T Nguyen; S A Kalams; B D Walker; R P Johnson; O O Yang
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

9.  Pathways utilized by dendritic cells for binding, uptake, processing and presentation of antigens derived from HIV-1.

Authors:  Rachel L Sabado; Ethan Babcock; Daniel G Kavanagh; Veronica Tjomsland; Bruce D Walker; Jeffrey D Lifson; Nina Bhardwaj; Marie Larsson
Journal:  Eur J Immunol       Date:  2007-07       Impact factor: 5.532

10.  Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.

Authors:  A Sijts; M Camps; R Offringa; C Melief; P M Kloetzel; F Ossendorp
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

View more
  15 in total

Review 1.  HIV-specific CD8⁺ T cells and HIV eradication.

Authors:  R Brad Jones; Bruce D Walker
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

2.  The Activation State of CD4 T Cells Alters Cellular Peptidase Activities, HIV Antigen Processing, and MHC Class I Presentation in a Sequence-Dependent Manner.

Authors:  Julie Boucau; Julien Madouasse; Georgio Kourjian; Christopher S Carlin; Daniel Wambua; Matthew J Berberich; Sylvie Le Gall
Journal:  J Immunol       Date:  2019-04-01       Impact factor: 5.422

3.  Analysis of Major Histocompatibility Complex-Bound HIV Peptides Identified from Various Cell Types Reveals Common Nested Peptides and Novel T Cell Responses.

Authors:  Marijana Rucevic; Georgio Kourjian; Julie Boucau; Renata Blatnik; Wilfredo Garcia Bertran; Matthew J Berberich; Bruce D Walker; Angelika B Riemer; Sylvie Le Gall
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 4.  Antigen processing and presentation in HIV infection.

Authors:  Julie Boucau; Sylvie Le Gall
Journal:  Mol Immunol       Date:  2018-04-07       Impact factor: 4.407

5.  HIV Protease Inhibitor-Induced Cathepsin Modulation Alters Antigen Processing and Cross-Presentation.

Authors:  Georgio Kourjian; Marijana Rucevic; Matthew J Berberich; Jens Dinter; Daniel Wambua; Julie Boucau; Sylvie Le Gall
Journal:  J Immunol       Date:  2016-03-23       Impact factor: 5.422

Review 6.  Challenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV Reservoirs.

Authors:  Mark A Brockman; R Brad Jones; Zabrina L Brumme
Journal:  Front Immunol       Date:  2015-10-02       Impact factor: 7.561

7.  Variable processing and cross-presentation of HIV by dendritic cells and macrophages shapes CTL immunodominance and immune escape.

Authors:  Jens Dinter; Ellen Duong; Nicole Y Lai; Matthew J Berberich; Georgio Kourjian; Edith Bracho-Sanchez; Duong Chu; Hang Su; Shao Chong Zhang; Sylvie Le Gall
Journal:  PLoS Pathog       Date:  2015-03-17       Impact factor: 6.823

8.  Acute Pharmacologic Degradation of a Stable Antigen Enhances Its Direct Presentation on MHC Class I Molecules.

Authors:  Sarah C Moser; Jane S A Voerman; Dennis L Buckley; Georg E Winter; Christopher Schliehe
Journal:  Front Immunol       Date:  2018-01-08       Impact factor: 7.561

9.  In vitro evaluation of digestive and endolysosomal enzymes to cleave CML-modified Ara h 1 peptides.

Authors:  Christopher P Mattison; Jens Dinter; Matthew J Berberich; Si-Yin Chung; Shawndrika S Reed; Sylvie Le Gall; Casey C Grimm
Journal:  Food Sci Nutr       Date:  2015-03-12       Impact factor: 2.863

10.  Increased translocation of antigens to endosomes and TLR4 mediated endosomal recruitment of TAP contribute to nicotine augmented cross-presentation.

Authors:  Yan Yan Wang; Chun Fang Hu; Juan Li; Xiang You; Feng Guang Gao
Journal:  Oncotarget       Date:  2016-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.